IGF1R and neuroblastoma: Drugs with the highest Selectivity Score included several already in investigation in neuroblastoma (Fig. 1A; Supplementary Data Table S1), for example, ranked #3 and #4 were IGF1R inhibitors (linsitinib and BMS-754807)20.